Suchergebnisse - "Liang, Chi-Xiong"

PubPharm (8)

1

Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma : a single-arm phase 2 trial

enthalten in: Nature communications | 2024

von Cao, X. | Huang, H. | Liang, C. | +13

2

Incidence, consequences, and predictors of serious chemotherapy-induced thrombocytopenia in nasopharyngeal carcinoma

enthalten in: Cancer medicine | 2023

von Zhang, L. | Chen, X. | Huang, Y. | +9

3

Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma

enthalten in: Lipids in health and disease | 2023

von Chen, X. | Li, Y. | Cao, X. | +15

4

Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma

enthalten in: Lipids in health and disease | 2023

von Chen, X. | Li, Y. | Cao, X. | +15

5

Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma

enthalten in: Lipids in health and disease | 2023

von Chen, X. | Li, Y. | Cao, X. | +15

6

Incidence, consequences, and predictors of serious chemotherapy‐induced thrombocytopenia in nasopharyngeal carcinoma

enthalten in: Cancer Medicine | 2023

von Zhang, L. | Chen, X. | Huang, Y. | +9

7

Add-on individualizing prediction of nasopharyngeal carcinoma using deep-learning based on MRI : A multicentre, validation study

enthalten in: iScience | 2022

von Cao, X. | Chen, X. | Lin, Z. | +9

8

Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy : A Phase 3 Randomized Clinical Trial

enthalten in: JAMA oncology | 2022

von Liu, G. | Li, W. | Wang, D. | +14

CommentIn: JAMA Oncol. 2022 Apr 1;8(4):524-525. - PMID 35175303

1
[1]